[go: up one dir, main page]

SE9603466D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9603466D0
SE9603466D0 SE9603466A SE9603466A SE9603466D0 SE 9603466 D0 SE9603466 D0 SE 9603466D0 SE 9603466 A SE9603466 A SE 9603466A SE 9603466 A SE9603466 A SE 9603466A SE 9603466 D0 SE9603466 D0 SE 9603466D0
Authority
SE
Sweden
Prior art keywords
new compounds
peptides
heterodimers
absorbable
cys
Prior art date
Application number
SE9603466A
Other languages
Swedish (sv)
Inventor
Haakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603466A priority Critical patent/SE9603466D0/en
Publication of SE9603466D0 publication Critical patent/SE9603466D0/en
Priority to AU44061/97A priority patent/AU4406197A/en
Priority to PCT/SE1997/001552 priority patent/WO1998012213A2/en
Priority to ZA9708477A priority patent/ZA978477B/en
Priority to ARP970104369A priority patent/AR009805A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Physiologically active peptides of the formula (I): A-(-R1-)-xR2-Cys-R3-B, wherein each variable has the meaning defined in the description, the entire peptide sequence containing up to 20 amino acid residues; and homo- or heterodimers thereof. These peptides are absorbable by the epithelial cell lining in a mammal resulting in a modulated immune response and thereby a therapeutic effect against disease.
SE9603466A 1996-09-23 1996-09-23 New compounds SE9603466D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9603466A SE9603466D0 (en) 1996-09-23 1996-09-23 New compounds
AU44061/97A AU4406197A (en) 1996-09-23 1997-09-15 Cysteine containing peptides
PCT/SE1997/001552 WO1998012213A2 (en) 1996-09-23 1997-09-15 Cysteine containing peptides
ZA9708477A ZA978477B (en) 1996-09-23 1997-09-19 Cysteine containing peptides.
ARP970104369A AR009805A1 (en) 1996-09-23 1997-09-23 PEPTIDES CONTAINING CYSTEINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603466A SE9603466D0 (en) 1996-09-23 1996-09-23 New compounds

Publications (1)

Publication Number Publication Date
SE9603466D0 true SE9603466D0 (en) 1996-09-23

Family

ID=20403988

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603466A SE9603466D0 (en) 1996-09-23 1996-09-23 New compounds

Country Status (5)

Country Link
AR (1) AR009805A1 (en)
AU (1) AU4406197A (en)
SE (1) SE9603466D0 (en)
WO (1) WO1998012213A2 (en)
ZA (1) ZA978477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005218555B2 (en) * 2004-03-01 2008-01-03 Board Of Regents, The University Of Texas System Dimeric small molecule potentiators of apoptosis
EP2079309B1 (en) * 2007-04-12 2015-11-11 Joyant Pharmaceuticals Inc Smac mimetic dimers and trimers useful as anti-cancer agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142387A1 (en) * 1983-08-26 1985-05-22 Anda Biologicals Process for the preparation of vaccines specific for LH and HCG and process for their detection
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
AU679443B2 (en) * 1992-04-13 1997-07-03 Oklahoma Medical Research Foundation Methods and reagents for diagnosis of autoantibodies
US5753617A (en) * 1992-09-08 1998-05-19 Centocor, Inc. Peptide inhibitors of cellular adhesion
SE9403526D0 (en) * 1994-10-14 1994-10-14 Astra Ab New Peptides
WO1996013589A1 (en) * 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects

Also Published As

Publication number Publication date
AR009805A1 (en) 2000-05-03
AU4406197A (en) 1998-04-14
WO1998012213A3 (en) 1998-04-30
WO1998012213A2 (en) 1998-03-26
ZA978477B (en) 1998-03-23

Similar Documents

Publication Publication Date Title
IL105554A0 (en) Peptides of human papilloma virus for use in human t cell response inducing compositions
EP2327712A3 (en) Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
NO920252L (en) T CELLE-RECEPTOR PEPTIDES AS THERAPEUTIC AGENTS FOR AUTO-IMMUNE AND TIMELY DISEASES
DK0643726T3 (en) Human p53 protein peptides for use in compositions that induce human T cell response and human p53 protein
BR1100309A (en) Peptide and pharmaceutical composition to promote the release of growth hormone levels in animals
SE9504661D0 (en) New compounds
DE69126568D1 (en) New physiologically active pig peptide (CNP-53)
RU94041224A (en) PEPTIDES WITH ORGAN-PROTECTIVE ACTIVITY, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND THEIR USE IN THERAPY
BR9607336A (en) Amino acid compositions and their uses in clinical nutrition
DE69728914D1 (en) Pharmaceutical composition against tumors and infections caused by papillomaviruses
SE9403526D0 (en) New Peptides
RU97105374A (en) MODIFIED PROTEINS
SE9603468D0 (en) New compounds
TR200103339T2 (en) New LHRH-antagonists with improved solubility features.
ATE193022T1 (en) HEPARIN AND SULFATIDE BINDING PEPTIDES OF TYPE 1 OF THE RECURRING SEQUENCES OF HUMAN THROMBOSPONDIN
NO934320D0 (en) T cell receptor peptides as therapeutic agents for immune-related diseases
IT1299583B1 (en) USE OF HMG-I PROTEIN FOR THE PREPARATION OF MEDICATIONS WITH CYTOTOXIC ACTIVITY
SE9501067D0 (en) New peptides
DK1538162T3 (en) COMPOSITIONS TO CHANGE SLIMS SECRET
SE9603466D0 (en) New compounds
BG97123A (en) DERIVATIVES OF HUMAN BILE SALTS, LIPASE AND PHARMACEUTICAL COMPOSITIONS BASED THEREOF
DK0707473T3 (en) Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymer beads
ATE268181T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING ALGINATES
SE9603461D0 (en) New compounds
SE9603463D0 (en) New compounds